Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 9/2012

01.09.2012 | Retinal Disorders

Short- and mid-term repeatability of macular pigment optical density measurements using spectral fundus reflectance

verfasst von: Nikolaus Dragostinoff, René Marcel Werkmeister, Semira Kaya, Günther Weigert, Berthold Pemp, Stefan Sacu, Gerhard Garhöfer, Ursula Schmidt-Erfurth, Leopold Schmetterer

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 9/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Several methods have been proposed for measuring macular pigment optical density (MPOD). To date, none of the realized techniques can be considered as “gold standard”. A key issue for the clinical applicability of a method is its repeatability. In this study, we investigated short- and mid-term repeatability of MPOD measurements using reflectometry.

Methods

A total of 12 healthy young subjects were measured 5 times on 5 consecutive days. Repeatability over 6 months was investigated in patients with AMD. The data in AMD patients were taken from a recently published placebo controlled study investigating the effect of lutein supplementation on MPOD (n = 37; [1]). Four measurements over 6 months were used to calculate repeatability. Spectral fundus reflectance of the fovea was measured in a 2.3° detection field with a custom-built fundus reflectometer. Calculation of MPOD was based on a previously published fundus reflectance model.

Results

The coefficients of variation were 6.2 ± 2.4% and 8.0 ± 5.5% in the healthy and AMD group, respectively. Bland–Altman plots indicate that the difference between measurements at day 1 and day 5 in healthy subjects and day 1 and month 6 in AMD patients was small. The maximum deviation in MPOD in a healthy subject was 0.07 (22.6%), and 0.17 (51.5%) in a patient with AMD.

Conclusions

Reflectometry provides adequate short-term and mid-term repeatability for measuring MPOD. Accordingly, the technique makes it possible to monitor MPOD in patients with AMD and to study the influence of supplementation in these subjects. In addition, the variability of the technique is small enough to allow for clinical trials with reasonable sample size.
Literatur
1.
Zurück zum Zitat Weigert G, Kaya S, Pemp B, Lasta M, Sacu S, Werkmeister R, Dragostinoff N, Simader C, Garhofer G, Schmetterer L (2011) Effects of lutein supplementation on macular pigment optical density and visual acuity in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci 52(11):8174–8178PubMedCrossRef Weigert G, Kaya S, Pemp B, Lasta M, Sacu S, Werkmeister R, Dragostinoff N, Simader C, Garhofer G, Schmetterer L (2011) Effects of lutein supplementation on macular pigment optical density and visual acuity in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci 52(11):8174–8178PubMedCrossRef
2.
Zurück zum Zitat Jager RD, Mieler WF, Miller JW (2008) Age-related macular degeneration. N Engl J Med 358:2606–2617PubMedCrossRef Jager RD, Mieler WF, Miller JW (2008) Age-related macular degeneration. N Engl J Med 358:2606–2617PubMedCrossRef
3.
4.
Zurück zum Zitat Wong TY, Chakravarthy U, Klein R, Mitchell P, Zlateva G, Buggage R, Fahrbach K, Probst C, Sledge I (2008) The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Ophthalmology 115:116–126PubMedCrossRef Wong TY, Chakravarthy U, Klein R, Mitchell P, Zlateva G, Buggage R, Fahrbach K, Probst C, Sledge I (2008) The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Ophthalmology 115:116–126PubMedCrossRef
5.
Zurück zum Zitat Submacular Surgery Trials Research Group, Solomon SD, Jefferys JL, Hawkins BS, Bressler NM, Bressler SB (2009) Risk factors for second eye progression to advanced age-related macular degeneration: SST report No. 21 Submacular Surgery Trials Research Group. Retina 29:1080–1090PubMedCrossRef Submacular Surgery Trials Research Group, Solomon SD, Jefferys JL, Hawkins BS, Bressler NM, Bressler SB (2009) Risk factors for second eye progression to advanced age-related macular degeneration: SST report No. 21 Submacular Surgery Trials Research Group. Retina 29:1080–1090PubMedCrossRef
6.
Zurück zum Zitat Feigl B (2009) Age-related maculopathy - linking aetiology and pathophysiological changes to the ischaemia hypothesis. Prog Retin Eye Res 28:63–86PubMedCrossRef Feigl B (2009) Age-related maculopathy - linking aetiology and pathophysiological changes to the ischaemia hypothesis. Prog Retin Eye Res 28:63–86PubMedCrossRef
7.
Zurück zum Zitat Boltz A, Luksch A, Wimpissinger B, Maar N, Weigert G, Frantal S, Brannath W, Garhöfer G, Ergun E, Stur M, Schmetterer L (2010) Choroidal blood flow and progression of age-related macular degeneration in the fellow eye in patients with unilateral choroidal neovascularization. Invest Ophthalmol Vis Sci 51:4220–4225PubMedCrossRef Boltz A, Luksch A, Wimpissinger B, Maar N, Weigert G, Frantal S, Brannath W, Garhöfer G, Ergun E, Stur M, Schmetterer L (2010) Choroidal blood flow and progression of age-related macular degeneration in the fellow eye in patients with unilateral choroidal neovascularization. Invest Ophthalmol Vis Sci 51:4220–4225PubMedCrossRef
8.
Zurück zum Zitat Boltz A, Lasta M, Schmidl D, Kaya S, Garhöfer G, Schmetterer L (2010) Risk factors for age-related macular degeneration. Spektrum Augenheilkd 24:296–304CrossRef Boltz A, Lasta M, Schmidl D, Kaya S, Garhöfer G, Schmetterer L (2010) Risk factors for age-related macular degeneration. Spektrum Augenheilkd 24:296–304CrossRef
9.
Zurück zum Zitat Deangelis MM, Silveira AC, Carr EA, Kim IK (2011) Genetics of age-related macular degeneration: current concepts, future directions. Semin Ophthalmol 26:77–93PubMedCrossRef Deangelis MM, Silveira AC, Carr EA, Kim IK (2011) Genetics of age-related macular degeneration: current concepts, future directions. Semin Ophthalmol 26:77–93PubMedCrossRef
10.
Zurück zum Zitat Beatty S, Koh H, Phil M, Henson D, Boulton M (2000) The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 45:115–134PubMedCrossRef Beatty S, Koh H, Phil M, Henson D, Boulton M (2000) The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 45:115–134PubMedCrossRef
11.
Zurück zum Zitat Khandhadia S, Lotery A (2010) Oxidation and age-related macular degeneration: insights from molecular biology. Expert Rev Mol Med 12:e34PubMedCrossRef Khandhadia S, Lotery A (2010) Oxidation and age-related macular degeneration: insights from molecular biology. Expert Rev Mol Med 12:e34PubMedCrossRef
12.
Zurück zum Zitat Fletcher AE (2010) Free radicals, antioxidants and eye diseases: evidence from epidemiological studies on cataract and age-related macular degeneration. Ophthalmic Res 44:191–198PubMedCrossRef Fletcher AE (2010) Free radicals, antioxidants and eye diseases: evidence from epidemiological studies on cataract and age-related macular degeneration. Ophthalmic Res 44:191–198PubMedCrossRef
13.
Zurück zum Zitat Nolan JM, Stack J, O' Donovan O, Loane E, Beatty S (2007) Risk factors for age-related maculopathy are associated with a relative lack of macular pigment. Exp Eye Res 84:61–74PubMedCrossRef Nolan JM, Stack J, O' Donovan O, Loane E, Beatty S (2007) Risk factors for age-related maculopathy are associated with a relative lack of macular pigment. Exp Eye Res 84:61–74PubMedCrossRef
14.
Zurück zum Zitat Beatty S, van Kuijk FJ, Chakravarthy U (2008) Macular pigment and age-related macular degeneration: longitudinal data and better techniques of measurement are needed. Invest Ophthalmol Vis Sci 49:843–845PubMedCrossRef Beatty S, van Kuijk FJ, Chakravarthy U (2008) Macular pigment and age-related macular degeneration: longitudinal data and better techniques of measurement are needed. Invest Ophthalmol Vis Sci 49:843–845PubMedCrossRef
15.
Zurück zum Zitat Howells O, Eperjesi F, Bartlett H (2011) Measuring macular pigment optical density in vivo: a review of techniques. Graefes Arch Clin Exp Ophthalmol 249:315–347PubMedCrossRef Howells O, Eperjesi F, Bartlett H (2011) Measuring macular pigment optical density in vivo: a review of techniques. Graefes Arch Clin Exp Ophthalmol 249:315–347PubMedCrossRef
16.
Zurück zum Zitat Bernstein PS, Delori FC, Richer S, van Kuijk FJ, Wenzel AJ (2010) The value of measurement of macular carotenoid pigment optical densities and distributions in age-related macular degeneration and other retinal disorders. Vision Res 50:716–728PubMedCrossRef Bernstein PS, Delori FC, Richer S, van Kuijk FJ, Wenzel AJ (2010) The value of measurement of macular carotenoid pigment optical densities and distributions in age-related macular degeneration and other retinal disorders. Vision Res 50:716–728PubMedCrossRef
17.
Zurück zum Zitat Moeller SM, Parekh N, Tinker L, Ritenbaugh C, Blodi B, Wallace RB, Mares JA, CAREDS Research Study Group (2006) Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-related Eye Disease Study (CAREDS): ancillary study of the Women's Health Initiative. Arch Ophthalmol 124:1151–1162PubMedCrossRef Moeller SM, Parekh N, Tinker L, Ritenbaugh C, Blodi B, Wallace RB, Mares JA, CAREDS Research Study Group (2006) Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-related Eye Disease Study (CAREDS): ancillary study of the Women's Health Initiative. Arch Ophthalmol 124:1151–1162PubMedCrossRef
18.
Zurück zum Zitat Tan JS, Wang JJ, Flood V, Rochtchina E, Smith W, Mitchell P (2008) Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology 115:334–341PubMedCrossRef Tan JS, Wang JJ, Flood V, Rochtchina E, Smith W, Mitchell P (2008) Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology 115:334–341PubMedCrossRef
19.
Zurück zum Zitat Group Age-Related Eye Disease Study Research, SanGiovanni JP, Chew EY, Clemons TE, Ferris FL 3rd, Gensler G, Lindblad AS, Milton RC, Seddon JM, Sperduto RD (2007) The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case–control study: AREDS Report No. 22. Arch Ophthalmol 125:1225–1232CrossRef Group Age-Related Eye Disease Study Research, SanGiovanni JP, Chew EY, Clemons TE, Ferris FL 3rd, Gensler G, Lindblad AS, Milton RC, Seddon JM, Sperduto RD (2007) The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case–control study: AREDS Report No. 22. Arch Ophthalmol 125:1225–1232CrossRef
20.
Zurück zum Zitat Beatty S, Murray IJ, Henson DB, Carden D, Koh H, Boulton ME (2001) Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest Ophthalmol Vis Sci 42:439–446PubMed Beatty S, Murray IJ, Henson DB, Carden D, Koh H, Boulton ME (2001) Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest Ophthalmol Vis Sci 42:439–446PubMed
21.
Zurück zum Zitat Bernstein PS, Zhao DY, Wintch SW, Ermakov IV, McClane RW, Gellermann (2002) Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients. Ophthalmology 109:1780–1787PubMedCrossRef Bernstein PS, Zhao DY, Wintch SW, Ermakov IV, McClane RW, Gellermann (2002) Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients. Ophthalmology 109:1780–1787PubMedCrossRef
22.
Zurück zum Zitat Berendschot TT, Willemse-Assink JJ, Bastiaanse M, de Jong PT, van Norren D (2002) Macular pigment and melanin in age-related maculopathy in a general population. Invest Ophthalmol Vis Sci 43:1928–1932PubMed Berendschot TT, Willemse-Assink JJ, Bastiaanse M, de Jong PT, van Norren D (2002) Macular pigment and melanin in age-related maculopathy in a general population. Invest Ophthalmol Vis Sci 43:1928–1932PubMed
23.
Zurück zum Zitat Ciulla TA, Hammond BR Jr (2004) Macular pigment density and aging, assessed in the normal elderly and those with cataracts and age-related macular degeneration. Am J Ophthalmol 138:582–587PubMedCrossRef Ciulla TA, Hammond BR Jr (2004) Macular pigment density and aging, assessed in the normal elderly and those with cataracts and age-related macular degeneration. Am J Ophthalmol 138:582–587PubMedCrossRef
24.
Zurück zum Zitat Jahn C, Wüstemeyer H, Brinkmann C, Trautmann S, Mössner A, Wolf S (2005) Macular pigment density in age-related maculopathy. Graefes Arch Clin Exp Ophthalmol 243:222–227PubMedCrossRef Jahn C, Wüstemeyer H, Brinkmann C, Trautmann S, Mössner A, Wolf S (2005) Macular pigment density in age-related maculopathy. Graefes Arch Clin Exp Ophthalmol 243:222–227PubMedCrossRef
25.
Zurück zum Zitat LaRowe TL, Mares JA, Snodderly DM, Klein ML, Wooten BR, Chappell R, CAREDS Macular Pigment Study Group (2008) Macular pigment density and age-related maculopathy in the Carotenoids in Age-Related Eye Disease Study. An ancillary study of the women's health initiative. Ophthalmology 115:876–883PubMedCrossRef LaRowe TL, Mares JA, Snodderly DM, Klein ML, Wooten BR, Chappell R, CAREDS Macular Pigment Study Group (2008) Macular pigment density and age-related maculopathy in the Carotenoids in Age-Related Eye Disease Study. An ancillary study of the women's health initiative. Ophthalmology 115:876–883PubMedCrossRef
26.
Zurück zum Zitat Hagen S, Krebs I, Glittenberg C, Binder S (2010) Repeated measures of macular pigment optical density to test reproducibility of heterochromatic flicker photometry. Acta Ophthalmol 88:207–211PubMedCrossRef Hagen S, Krebs I, Glittenberg C, Binder S (2010) Repeated measures of macular pigment optical density to test reproducibility of heterochromatic flicker photometry. Acta Ophthalmol 88:207–211PubMedCrossRef
27.
Zurück zum Zitat de Kinkelder R, van der Veen RL, Verbaak FD, Faber DJ, van Leeuwen TG, Berendschot TT (2011) Macular pigment optical density measurements: evaluation of a device using heterochromatic flicker photometry. Eye 25:105–112PubMedCrossRef de Kinkelder R, van der Veen RL, Verbaak FD, Faber DJ, van Leeuwen TG, Berendschot TT (2011) Macular pigment optical density measurements: evaluation of a device using heterochromatic flicker photometry. Eye 25:105–112PubMedCrossRef
28.
Zurück zum Zitat Sasamoto Y, Gomi F, Sawa M, Sakaguchi H, Tsujikawa M, Nishida K (2011) Effect of cataract in evaluation of macular pigment optical density by autofluorescence spectrometry. Invest Ophthalmol Vis Sci 52:927–932PubMedCrossRef Sasamoto Y, Gomi F, Sawa M, Sakaguchi H, Tsujikawa M, Nishida K (2011) Effect of cataract in evaluation of macular pigment optical density by autofluorescence spectrometry. Invest Ophthalmol Vis Sci 52:927–932PubMedCrossRef
29.
Zurück zum Zitat Berendschot TT, van Norren D (2004) Objective determination of the macular pigment optical density using fundus reflectance spectroscopy. Arch Biochem Biophys 430:149–155PubMedCrossRef Berendschot TT, van Norren D (2004) Objective determination of the macular pigment optical density using fundus reflectance spectroscopy. Arch Biochem Biophys 430:149–155PubMedCrossRef
30.
Zurück zum Zitat Group Age-Related Eye Disease Study Research (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 119:1417–1436CrossRef Group Age-Related Eye Disease Study Research (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 119:1417–1436CrossRef
31.
Zurück zum Zitat Zagers NP, van de Kraats J, Berendschot TT, van Norren D (2002) Simultaneous measurement of foveal spectral reflectance and cone-photoreceptor directionality. Appl Opt 41:4686–4696PubMedCrossRef Zagers NP, van de Kraats J, Berendschot TT, van Norren D (2002) Simultaneous measurement of foveal spectral reflectance and cone-photoreceptor directionality. Appl Opt 41:4686–4696PubMedCrossRef
32.
Zurück zum Zitat Chiu CJ, Milton RC, Klein R, Gensler G, Taylor A (2009) Dietary compound score and risk of age-related macular degeneration in the age-related eye disease study. Ophthalmology 116:939–946PubMedCrossRef Chiu CJ, Milton RC, Klein R, Gensler G, Taylor A (2009) Dietary compound score and risk of age-related macular degeneration in the age-related eye disease study. Ophthalmology 116:939–946PubMedCrossRef
33.
Zurück zum Zitat Ho L, van Leeuwen R, Witteman JC, van Duijn CM, Uitterlinden AG, Hofman A, de Jong PT, Vingerling JR, Klaver CC (2011) Reducing the genetic risk of age-related macular degeneration with dietary antioxidants, zinc, and {omega}-3 fatty acids: The Rotterdam Study. Arch Ophthalmol 129:758–766PubMedCrossRef Ho L, van Leeuwen R, Witteman JC, van Duijn CM, Uitterlinden AG, Hofman A, de Jong PT, Vingerling JR, Klaver CC (2011) Reducing the genetic risk of age-related macular degeneration with dietary antioxidants, zinc, and {omega}-3 fatty acids: The Rotterdam Study. Arch Ophthalmol 129:758–766PubMedCrossRef
34.
Zurück zum Zitat Berendschot TT, Goldbohm RA, Klopping WA, van de Kraats J, van Norel J, van Norren D (2000) Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Invest Ophthalmol Vis Sci 41:3322–3326PubMed Berendschot TT, Goldbohm RA, Klopping WA, van de Kraats J, van Norel J, van Norren D (2000) Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Invest Ophthalmol Vis Sci 41:3322–3326PubMed
35.
Zurück zum Zitat Richer S, Stiles W, Statkute L, Pulido J, Frankowski J, Rudy D, Pei K, Tsipursky M, Nyland J (2004) Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry 75:216–230PubMedCrossRef Richer S, Stiles W, Statkute L, Pulido J, Frankowski J, Rudy D, Pei K, Tsipursky M, Nyland J (2004) Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry 75:216–230PubMedCrossRef
36.
Zurück zum Zitat Schalch W, Cohn W, Barker FM, Köpcke W, Mellerio J, Bird AC, Robson AG, Fitzke FF, van Kuijk FJ (2007) Xanthophyll accumulation in the human retina during supplementation with lutein or zeaxanthin - the LUXEA (LUtein Xanthophyll Eye Accumulation) study. Arch Biochem Biophys 458:128–135PubMedCrossRef Schalch W, Cohn W, Barker FM, Köpcke W, Mellerio J, Bird AC, Robson AG, Fitzke FF, van Kuijk FJ (2007) Xanthophyll accumulation in the human retina during supplementation with lutein or zeaxanthin - the LUXEA (LUtein Xanthophyll Eye Accumulation) study. Arch Biochem Biophys 458:128–135PubMedCrossRef
37.
Zurück zum Zitat Trieschmann M, Beatty S, Nolan JM, Hense HW, Heimes B, Austermann U, Fobker M, Pauleikhoff D (2007) Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study. Exp Eye Res 84:718–728PubMedCrossRef Trieschmann M, Beatty S, Nolan JM, Hense HW, Heimes B, Austermann U, Fobker M, Pauleikhoff D (2007) Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study. Exp Eye Res 84:718–728PubMedCrossRef
38.
Zurück zum Zitat Johnson EJ, Chung HY, Caldarella SM, Snodderly DM (2008) The influence of supplemental lutein and docosahexaenoic acid on serum, lipoproteins, and macular pigmentation. Am J Clin Nutr 87:1521–1529PubMed Johnson EJ, Chung HY, Caldarella SM, Snodderly DM (2008) The influence of supplemental lutein and docosahexaenoic acid on serum, lipoproteins, and macular pigmentation. Am J Clin Nutr 87:1521–1529PubMed
39.
Zurück zum Zitat Bone RA, Landrum JT (2010) Dose-dependent response of serum lutein and macular pigment optical density to supplementation with lutein esters. Arch Biochem Biophys 504:50–5PubMedCrossRef Bone RA, Landrum JT (2010) Dose-dependent response of serum lutein and macular pigment optical density to supplementation with lutein esters. Arch Biochem Biophys 504:50–5PubMedCrossRef
40.
Zurück zum Zitat Connolly EE, Beatty S, Thurnham DI, Loughman J, Howard AN, Stack J, Nolan JM (2010) Augmentation of macular pigment following supplementation with all three macular carotenoids: an exploratory study. Curr Eye Res 35:335–351PubMedCrossRef Connolly EE, Beatty S, Thurnham DI, Loughman J, Howard AN, Stack J, Nolan JM (2010) Augmentation of macular pigment following supplementation with all three macular carotenoids: an exploratory study. Curr Eye Res 35:335–351PubMedCrossRef
41.
Zurück zum Zitat Dietzel M, Zeimer M, Heimes B, Claes B, Pauleikhoff D, Hense HW (2011) Determinants of macular pigment optical density and its relation to age-related maculopathy: results from the Muenster Aging and Retina Study (MARS). Invest Ophthalmol Vis Sci 52:3452–3457PubMedCrossRef Dietzel M, Zeimer M, Heimes B, Claes B, Pauleikhoff D, Hense HW (2011) Determinants of macular pigment optical density and its relation to age-related maculopathy: results from the Muenster Aging and Retina Study (MARS). Invest Ophthalmol Vis Sci 52:3452–3457PubMedCrossRef
42.
Zurück zum Zitat Barker FM 2nd, Snodderly DM, Johnson EJ, Schalch W, Koepcke W, Gerss J, Neuringer M (2011) Nutritional manipulation of primate retinas, V: effects of lutein, zeaxanthin, and n-3 fatty acids on retinal sensitivity to blue-light-induced damage. Invest Ophthalmol Vis Sci 52:3934–3942PubMedCrossRef Barker FM 2nd, Snodderly DM, Johnson EJ, Schalch W, Koepcke W, Gerss J, Neuringer M (2011) Nutritional manipulation of primate retinas, V: effects of lutein, zeaxanthin, and n-3 fatty acids on retinal sensitivity to blue-light-induced damage. Invest Ophthalmol Vis Sci 52:3934–3942PubMedCrossRef
43.
Zurück zum Zitat Curran Celentano J, Burke JD, Hammond BR Jr (2002) In vivo assessment of retinal carotenoids: macular pigment detection techniques and their impact on monitoring pigment status. J Nutr 132:535S–539SPubMed Curran Celentano J, Burke JD, Hammond BR Jr (2002) In vivo assessment of retinal carotenoids: macular pigment detection techniques and their impact on monitoring pigment status. J Nutr 132:535S–539SPubMed
44.
Zurück zum Zitat Delori FC, Goger DG, Hammond BR, Snodderly DM, Burns SA (2001) Macular pigment density measured by autofluorescence spectrometry: comparison with reflectometry and heterochromatic flicker photometry. J Opt Soc Am A Opt Image Sci Vis 18:1212–1230PubMedCrossRef Delori FC, Goger DG, Hammond BR, Snodderly DM, Burns SA (2001) Macular pigment density measured by autofluorescence spectrometry: comparison with reflectometry and heterochromatic flicker photometry. J Opt Soc Am A Opt Image Sci Vis 18:1212–1230PubMedCrossRef
45.
Zurück zum Zitat Wüstemeyer H, Jahn C, Nestler A, Barth T, Wolf S (2002) A new instrument for the quantification of macular pigment density: first results in patients with AMD and healthy subjects. Graefes Arch Clin Exp Ophthalmol 240:666–667PubMedCrossRef Wüstemeyer H, Jahn C, Nestler A, Barth T, Wolf S (2002) A new instrument for the quantification of macular pigment density: first results in patients with AMD and healthy subjects. Graefes Arch Clin Exp Ophthalmol 240:666–667PubMedCrossRef
46.
Zurück zum Zitat Berendschot TT, van Norren D (2005) On the age dependency of the macular pigment optical density. Exp Eye Res 81:602–609PubMedCrossRef Berendschot TT, van Norren D (2005) On the age dependency of the macular pigment optical density. Exp Eye Res 81:602–609PubMedCrossRef
47.
Zurück zum Zitat van de Kraats J, Berendschot TT, Valen S, van Norren D (2006) Fast assessment of the central macular pigment density with natural pupil using the macular pigment reflectometer. J Biomed Opt 11:064031PubMedCrossRef van de Kraats J, Berendschot TT, Valen S, van Norren D (2006) Fast assessment of the central macular pigment density with natural pupil using the macular pigment reflectometer. J Biomed Opt 11:064031PubMedCrossRef
48.
Zurück zum Zitat Bone RA, Brener B, Gibert JC (2007) Macular pigment, photopigments, and melanin: distributions in young subjects determined by four-wavelength reflectometry. Vision Res 47:3259–3268PubMedCrossRef Bone RA, Brener B, Gibert JC (2007) Macular pigment, photopigments, and melanin: distributions in young subjects determined by four-wavelength reflectometry. Vision Res 47:3259–3268PubMedCrossRef
49.
Zurück zum Zitat Gellermann W, Bernstein PS (2004) Noninvasive detection of macular pigments in the human eye. J Biomed Opt 9:75–85PubMedCrossRef Gellermann W, Bernstein PS (2004) Noninvasive detection of macular pigments in the human eye. J Biomed Opt 9:75–85PubMedCrossRef
Metadaten
Titel
Short- and mid-term repeatability of macular pigment optical density measurements using spectral fundus reflectance
verfasst von
Nikolaus Dragostinoff
René Marcel Werkmeister
Semira Kaya
Günther Weigert
Berthold Pemp
Stefan Sacu
Gerhard Garhöfer
Ursula Schmidt-Erfurth
Leopold Schmetterer
Publikationsdatum
01.09.2012
Verlag
Springer-Verlag
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 9/2012
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-012-1946-3

Weitere Artikel der Ausgabe 9/2012

Graefe's Archive for Clinical and Experimental Ophthalmology 9/2012 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.